Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus PK-guided dosing in kidney transplant
NCT00297310Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2004
- Primary completion
- Oct 2006
- Modality
- RNA-Targeting Small Molecules
01
Overview
A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by Janssen Pharmaceutical. Started May 2004; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00297310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00297310.